BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Kepivance®: Restriction of indication

Active substance: palifermin

Indication for Kepivance® restricted to patients exposed to radiotherapy and chemotherapy for conditioning prior to autologous stem cell transplantation.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 2MB, File is accessible